helix chemical supply tirzepatide February 20, 2024: FDA warns companies selling unapproved semaglutide and – Partnership for Safe Medicines Peptides as Therapeutic Agents: Challenges

Dec 2021;37(12):1079-1085

it takes around 10 seconds

Zepbound (tirzepatide) was FDA-approved in November 2023 for chronic weight management in adults with obesity (BMI 30+) or overweight (BMI 27+) with a weight-related condition

None of these look anything like a large GLP-1 analog peptide under the antibody-based assays used in standard testing

Acknowledgements The authors acknowledge the support of grants from Inserm, CNRS, Universit Paris Cit, Agence Nationale de la Recherche (ANR), Socit Francophone du Diabte (SFD), Fondation pour la Recherche Mdicale (FRM), the Dutch Organization for Scientific Research (ZonMW) and DiabetesFonds

The primary concern is hypoglycemia, which is manageable with proper nutrition timing